Orion Corporation A (FI0009014369) — research page
FI · fi-cm-kg/XHEL/FI0009014369 · as of 2026-11-06
Identity and listing
The issuer is Orion Corporation A, listed on Nasdaq Helsinki under ticker FI0009014369, with ISIN FI0009014369 and LEI 74370029VAHCXDR7B745. Its security type, segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Orion Corporation A | source · 2026-11-06 |
| exchange | Nasdaq Helsinki | source · 2026-11-06 |
| ticker | FI0009014369 | source · 2026-11-06 |
| ISIN | FI0009014369 | source · 2026-11-06 |
| LEI | 74370029VAHCXDR7B745 | source · 2026-11-06 |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 93 filings in the twelve months to 2026-11-06, across 68 filing days. The median gap between filing days is 4 days. The latest filing is an Interim report (Q1 and Q3) dated 2026-10-28, 9 days before the record date. The Nasdaq Helsinki exchange median is 7.0 days for cadence gap and 7.0 days for latency, with a median of 50 filings across 151 issuers. The sector median is not on the record.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 93 | 4 | 9 |
| exchange median: Nasdaq Helsinki (151 issuers) | 50 | 7 | 7 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-28 | Interim report (Q1 and Q3) | Interim report (Q1 and Q3) | Orion Group Interim report January-September 2026: Strong financial performance and positive developments in the R&D pipeline |
| 2026-10-26 | Changes board/management/auditors | Changes board/management/auditors | Changes in Orion Group's Executive Team as of 1 January 2027 |
| 2026-10-24 | Investor News | Investor News | Darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence |
| 2026-10-20 | Inside information | Inside information | Inside information: Orion upgrades full-year outlook for 2026 |
| 2026-10-14 | Investor News | Investor News | Orion publishes Interim Report for January-September 2026 and holds a webcast on 28 October 2026 |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is not on the record, and neither is its location. The market's record does not carry auditor changes.
Events and halts
The record does not carry listing, delisting, name change, domicile change or segment move events for this market. The halt flag is listed, not halted.
Orderability
The orderability outcome is not determinable, because the chapter's orderability section carries no client categories. The rule version is acm-68000/fi/mifid-ii-product-governance/r1, with a chapter as-of date of 2026-11-04.
rule acm-68000/fi/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's investor-relations page names 7 research houses: DNB Carnegie, Danske Bank, Inderes, Jefferies, Nordea, SEB and Nordea OP.
| research house | analyst | source · read date |
|---|---|---|
| DNB Carnegie | Iiris Theman | issuer page · 2026-11-12 |
| Danske Bank | Sami Sarkamies | issuer page · 2026-11-12 |
| Inderes | Antti Siltanen | issuer page · 2026-11-12 |
| Jefferies | Shan Hama | issuer page · 2026-11-12 |
| Nordea | issuer page · 2026-11-12 | |
| SEB | Anssi Raussi | issuer page · 2026-11-12 |
| Nordea OP | Matti Kaurola | issuer page · 2026-11-12 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No issuer years are sealed, and the market's earliest sealed date and the live record start date are not on the record.
Sources
6 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://firds.esma.europa.eu/firds/ (identity.exchange)
- 10.2
- https://mcp.fi-cm-kg.ai/events/XHEL/FI0009014369 (the disclosure lines)
- 10.3
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=exchangeNewsFilterHEX|FirstNorthInformationHEX (the halt flag)
- 10.4
- https://fi.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.5
- https://www.orionpharma.com/investors/share-information/analysts/ (coverage)
- 10.6
- https://mcp.fi-cm-kg.ai/record/XHEL/FI0009014369 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"FI0009014369"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:dc55ad84421345e5.